T cells have also been shown to traffic to the BM efficiently via the CXCR4/CXCL12 axis in prostate cancer patients [59], which implies that adoptively transferred NK cells may also be able to traffic to the BM in leukemia patients. This evidence concerns the gene CXCL12 and prostate carcinoma.